Humanitarian crises spark 20% of new epidemics. See why 70% of epidemic deaths occur here and what strategies reduce outbreaks by 40%.
·
·
7 min read
Global vaccine trials show a 90% disparity in participant diversity. Learn why this matters for future disease access and what needs to change.
·
·
7 min read
2026 tariffs threaten life sciences supply chains. Learn how to map suppliers, diversify manufacturing, and use analytics to survive trade wars.
·
·
7 min read
Can vaccine IP balance ethics and profit? See how tiered pricing, WHO waivers, and new models are shaping equitable access for 2026.
·
·
7 min read
How can global vaccine trials be ethical and fast? See 5 imperatives for 2026, from centralized review to post-trial access, ensuring trust and progress.
·
·
8 min read
A $10 billion gap hinders vaccine equity in 2026. See why low-income nations still lack access & what's needed to fix it.
·
·
4 min read
Private enterprise is key to global health security. Learn how $150B in R&D and rapid innovation fight future pandemics.
·
·
8 min read
DRC faces pneumonic plague. Learn how WHO and local authorities are fighting the outbreak in 3 districts and what's next for global health.
·
·
5 min read
Emerging markets tightened currency controls in early 2026. See how this impacts foreign investment, why it matters, and what to watch next.
·
·
5 min read
The dollar's global role is shifting. See how de-dollarization impacts your business by 2026 and what steps to take for currency diversification.
·
·
9 min read